Markets:

Overview

News

Currencies

International

Treasuries

Adverum Biotechnologies, Inc. - Common Stock (NQ:ADVM)

4.190 +0.020 (+0.48%)

Streaming Delayed Price Updated: 11:24 AM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Adverum Biotechnologies, Inc. - Common Stock

< Previous 1 2 3 4 Next >

This Yum! Brands Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

November 17, 2025

Via Benzinga

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

November 17, 2025

Via Benzinga

This Dell Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday ↗

November 17, 2025

Via Benzinga

Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections ↗

October 24, 2025

Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for $12.47 per share, with potential CVR payments tied to future milestones.

Via Benzinga

Eli Lilly To Acquire Adverum Biotechnologies ↗

October 24, 2025

Via Stocktwits

In today's session, these stocks are experiencing unusual volume. ↗

September 24, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 22, 2025

Via Benzinga

Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗

April 17, 2025

Via Benzinga

Top movers in Wednesday's pre-market session ↗

April 09, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 31, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 05, 2024

Via Benzinga

ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q2 2024 ↗

August 12, 2024

ADVM stock results show that Adverum Biotechnologies beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying ↗

August 01, 2024

Via Benzinga

More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying ↗

July 19, 2024

Via Benzinga

Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study ↗

July 17, 2024

Adverum Biotechnologies presented 26-week interim data from the LUNA Phase 2 trial for Ixo-vec in wet AMD. The analysis showed significant reductions in anti-VEGF injections and positive visual...

Via Benzinga

Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

July 17, 2024

Via Benzinga

ADVM Stock Earnings: Adverum Biotechnologies Misses EPS for Q1 2024 ↗

May 09, 2024

ADVM stock results show that Adverum Biotechnologies missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 23, 2024

Via Benzinga

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 20, 2024

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...

Via Benzinga

ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q4 2023 ↗

March 18, 2024

ADVM stock results show that Adverum Biotechnologies beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Turn Pocket Change into Profit: 3 Penny Stocks Ready to Pop ↗

March 06, 2024

There are plenty of penny stocks ready to pop but we have to remember that penny stocks are extremely risky, too.

Via InvestorPlace

Stocks on the Launchpad: The Next 3 Market Sensations ↗

February 27, 2024

Navigate the bullish trend in the market by wagering on these three enticing market sensations likely to become multi-bagger investments

Via InvestorPlace

Unleash Massive Returns With These 3 Top Penny Stocks ↗

February 22, 2024

Our economy is doing well, and these top penny stocks are in position to benefit from this. Invest now and see strong returns.

Via InvestorPlace

Topics Economy

Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today? ↗

February 08, 2024

Adverum Biotechnologies' Ixo-vec gene therapy for wet AMD. Preliminary LUNA Phase 2 trial data show safety, efficacy, and significant treatment burden reduction.

Via Benzinga

Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 05, 2024

Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 05, 2024

Via Benzinga

Why Adverum Biotechnologies Stock Is Trading Higher ↗

February 05, 2024

Adverum will sell the shares at a price per share of $1.20, representing a premium of approximately 20% to its stock's 30-day volume-weighted average price, and the financing is expected to close on...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 05, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.